News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Boehringer Ingelheim acquires equine health startup Evax
startupticker.ch
-
London-based market intelligence company acquires Square Commodities
startupticker.ch
-
Vaderis Therapeutics closes USD 152 million Series B Financing
startupticker.ch
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
DTN Highlights
-
Read more: Swiss Scale-Up Report 2026: Built Here, Financed AbroadFor the first time, Switzerland’s scale-ups have been counted company by company. The Swiss Scale-Up Report 2026, published on September 16, 2026 by Deep Tech…
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Indivi secures CHF 15 million
TechBio company Indivi has closed a CHF15 million investment round led by Ava Investors to accelerate the validation and deployment of precision medicine tools in…
startupticker.ch
startupticker.ch: Indivi secures CHF 15 million- Indivi raised CHF15 million from Ava Investors to develop digital biomarkers for accelerating Alzheimer's drug development.
- The company's smartphone tools capture motor, cognitive, vision, and voice data for regulatory trials and clinical use.
- Indivi plans a 2026 trial to identify biomarkers for amyloid-depleting Alzheimer's therapies.
-
CHF 172 million for growth start-ups
Following the first closing of the Swisscanto (CH) Private Equity Switzerland Growth II fund, managed by Zürcher Kantonalbank, investment activities will now commence. The majority…
startupticker.ch
startupticker.ch: CHF 172 million for growth start-ups- Swisscanto Private Equity Switzerland Growth II raised CHF 171.65 million from 45 investors in eight months.
- The fund invests in Swiss growth companies with innovative tech in health, industry, and data services.
- Zürcher Kantonalbank's PE programs manage nearly CHF 500 million across three funds, including a decarbonisation fund.
-
NNAISENSE gets acquired by Germany asset management firm
Based in Lugano, NNAISENSE has built a generative AI framework for financial markets to enable the prediction of coherent market scenarios across multiple asset classes,…
startupticker.ch
startupticker.ch: NNAISENSE gets acquired by Germany asset management firm- ACATIS Investment KVG acquired NNAISENSE to gain exclusive access to its Large Investing Model for predicting financial market scenarios.
- NNAISENSE's LIM, developed by DeepMind's Alex Graves, analyzes multiple asset classes and macroeconomic, fundamental, and alternative data.
- NNAISENSE maintains its Lugano headquarters and will focus exclusively on developing the LIM for ACATIS's portfolio management.
-
Delvitech closes USD 40 million Series B round to accelerate global growth
Delvitech, specializing in the development of AI-native Automated Optical Inspection (AOI) solutions for electronics, closed a Series B investment round of USD 40 million. Delvitech…
startupticker.ch
startupticker.ch: Delvitech closes USD 40 million Series B round to accelerate global growth- Delvitech raised $40M in Series B funding to expand its AI-native optical inspection platform globally, with an Indian plant planned for 2026.
- Delvitech's neural networks and Swiss hardware enable predictive quality control that anticipates errors rather than detecting them in PCB components.
- Delvitech projects 400% sales growth by end of 2025 and added neural networks pioneer Prof.
-
Wellcome awards CHF 14 million for BioVersys’ BV100 Phase 2b study
BioVersys’ lead asset BV100, an innovative anti-infective developed for hospital infections caused by Acinetobacter baumannii, including carbapenem resistant strains (CRAB), has been selected to participate…
startupticker.ch
startupticker.ch: Wellcome awards CHF 14 million for BioVersys’ BV100 Phase 2b study- BioVersys' BV100, a novel IV rifabutin formulation, selected for ADVANCE-ID Phase 2b trial targeting carbapenem-resistant Acinetobacter baumannii.
- Wellcome funding of SGD 22 million enables first sponsor-driven ADVANCE-ID trial, expanding enrollment to 90 and adding combination therapy arms.
- First patient dosing expected H1 2026 with interim data H2 2026, supporting BV100's Phase 3 program for US, European, and Chinese submissions.
-
AstraZeneca acquires SixPeaks for up to USD 300 million
Following an initial investment of USD 15 million in 2024, AstraZeneca has acquired Basel-based SixPeaks Bio AG. SixPeaks is investigating potential therapies for weight-management with…
startupticker.ch
startupticker.ch: AstraZeneca acquires SixPeaks for up to USD 300 million- AstraZeneca acquired Basel-based SixPeaks Bio for up to $300M, exercising an option after a $15M 2024 investment.
- SixPeaks develops activin IIA/B receptor antibodies to preserve muscle mass, addressing a GLP-1 drug limitation.
- SixPeaks created a first-in-class GLP-1 antibody conjugate combining weight loss with muscle preservation.
-
Positrigo on a growth momentum in the US
One year following the acquisition of its first customer in the US market, Positrigo continues to strengthen its position in America. The company has installed…
startupticker.ch
startupticker.ch: Positrigo on a growth momentum in the US- Positrigo's FDA-cleared NeuroLF brain PET scanner is rapidly expanding in the US market with multiple installations.
- New Alzheimer's disease-modifying therapies are driving demand for brain PET scans, creating market opportunities.
- Positrigo expanded operations with new executives and board members, strengthening European distribution in Spain and France.
-
CDR-Life to receive up to CHF 456 million in license agreement with Boehringer Ingelheim
Building on their longstanding partnership in retinal health, Boehringer Ingelheim and CDR-Life, Inc. have entered a new global licensing agreement to develop CDR-Life’s antibody-based molecule…
startupticker.ch
startupticker.ch: CDR-Life to receive up to CHF 456 million in license agreement with Boehringer Ingelheim- Boehringer Ingelheim licensed CDR111, a trispecific antibody T-cell engager, with up to CHF 456M in milestone and royalty payments.
- CDR111 selectively depletes dysregulated B cells to reset immunity, potentially treating lupus, MS, and arthritis.
- The partnership expands prior collaboration on a Phase 2 geographic atrophy treatment, validating CDR-Life's platform.
-
CHF 28 million for Switzerland’s new Bitcoin treasury company
Future Holdings AG, Switzerland’s premier Bitcoin treasury company, has closed a CHF 28 million strategic funding round anchored by cornerstone investors Fulgur Ventures, Nakamoto, and…
startupticker.ch
startupticker.ch: CHF 28 million for Switzerland’s new Bitcoin treasury company- Future Holdings AG raised CHF 28 million from investors including Fulgur Ventures, Nakamoto, and TOBAM.
- The Swiss company offers institutional Bitcoin exposure in CHF with treasury, research, and advisory services.
- Future is led by CEO Sebastien Hess and co-founders from Syz Capital, Relai, and Blockstream.
-
Switzerland leads 69 nations in digital competitiveness
Switzerland, the US, and Singapore are the most digitally savvy nations among an eclectic group of 69 global economies, according to the 2025 IMD World…
startupticker.ch
startupticker.ch: Switzerland leads 69 nations in digital competitiveness- Switzerland leads the 2025 Digital Competitiveness Ranking in knowledge and talent, but ranks 55th in wireless broadband penetration.
- The US and Singapore round out the top three, but trade war uncertainty threatens their digital competitiveness sustainability.
- Infrastructure-heavy industries outperform while knowledge sectors underperform; venture capital scarcity constrains digital progress.
-
DeepJudge closes $41.2M Series A round
With revenues growing over 500% year-over-year, DeepJudge continues to establish itself as the go-to AI platform for legal professionals worldwide. Alongside new customers, the startup…
startupticker.ch
startupticker.ch: DeepJudge closes $41.2M Series A round- DeepJudge raised $41.2M Series A funding led by Felicis, reaching $300M valuation to expand its legal AI platform.
- DeepJudge's data-first approach lets law firms use internal knowledge without moving or restructuring their data.
- Major law firms like Freshfields, Holland & Knight, and Cozen O'Connor adopted DeepJudge after 500% YoY growth.
-
Mimic Robotics banks $16 million seed funding
Zurich-based robotics startup mimic has closed an oversubscribed $16 million funding round led by Elaia, alongside Speedinvest. The investment will be used to accelerate the…
startupticker.ch
startupticker.ch: Mimic Robotics banks $16 million seed funding- Mimic Robotics raised $16M to develop AI-powered humanoid hands trained on real-world factory worker demonstrations.
- The company uses imitation learning to train robots that autonomously adapt to objects and self-correct in human environments.
- Mimic pilots with Fortune 500 and automotive firms, converting lab AI into practical factory robotics solutions.
-
Read more: Switzerland: The Global Deep Tech LeaderSwitzerland was recently named a deep tech beacon by Forbes. Through data backed facts, discover why it’s even more than that; a global deep tech…
-
Read more: Deep Tech Startups Drive Swiss InvestmentMore venture capital went to Swiss startups from deep tech sectors such as biopharma and hardware & robotics in 2024 than in 2023 – and…
-
Read more: New Information Platform Aims to Boost Funding for Swiss Deep Tech ScaleupsDeep Tech Nation Switzerland Foundation and Startupticker Foundation announce the launch of the Deep Tech Nation Information Platform, a digital portal meant to facilitate investments…
-
Read more: Fajer Mushtaq, Clean Tech EntrepreneurFajer Mushtaq, co-founder and CEO of Oxyle, has raised about CHF 9 million in non-dilutive funds in recent years from innovation programmes, the public sector…
-
Read more: Andreas Brenner, Serial EntrepeneurAndreas Brenner started at the age of 28, when he founded Avrios.com. He spent seven years as CEO responsible for building an SaaS platform that…
-
Read more: Switzerland, Big Pharma’s Shopping CentreThe top pharmaceutical companies are very active in Switzerland, participating in large financing rounds and acquiring companies or drug candidates. In 2024, the global number…
-
Read more: Robots and the Swiss Tradition of Customer FocusFor Swiss robotics startups, customer success and investor success go hand in hand. In addition to outstanding technology, this requires a high degree of customer…